W.L.Gore & Associates
113
16
33
51
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
10.6%
12 terminated/withdrawn out of 113 trials
81.0%
-5.6% vs industry average
7%
8 trials in Phase 3/4
110%
56 of 51 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (113)
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Role: lead
TAMBE Japan Post-Marketing Surveillance
Role: lead
MBA Early Feasibility Study
Role: lead
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
Role: lead
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
Role: lead
Evaluation of the GORE® Ascending Stent Graft
Role: lead
Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels
Role: lead
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
Role: lead
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Role: lead
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Role: lead
PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Role: collaborator
Real-World Data Collection of the GORE Devices When Used in the Treatment of Aortic Pathologies Which Requires the Incorporation of the Visceral Arteries.
Role: lead
Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
Role: lead
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
Role: lead
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Role: lead
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Role: lead
GORE Glaucoma Drainage Implant Clinical Study Dominican Republic
Role: lead
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE)
Role: lead
GORE® ENFORM Biomaterial Product Study
Role: lead
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
Role: lead